Emmaus Life Sciences Valuation

EMMADelisted Stock  USD 0.13  0.00  0.00%   
Emmaus Life seems to be overvalued based on Macroaxis valuation methodology. Our model computes the value of Emmaus Life Sciences from reviewing the firm fundamentals such as Shares Outstanding of 49.56 M, operating margin of (0.65) %, and Shares Owned By Insiders of 38.73 % as well as analyzing its technical indicators and probability of bankruptcy. In general, most investors advise taking in undervalued instruments and trading overvalued instruments since, at some point, asset prices and their ongoing real values will submerge.
Overvalued
Today
0.13
Please note that Emmaus Life's price fluctuation is out of control at this time. Calculation of the real value of Emmaus Life Sciences is based on 3 months time horizon. Increasing Emmaus Life's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Our valuation method for Emmaus Life Sciences is useful when determining the fair value of the Emmaus otc stock, which is usually determined by what a typical buyer is willing to pay for full or partial control of Emmaus Life. Since Emmaus Life is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Emmaus OTC Stock. However, Emmaus Life's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value.
Historical Market  0.13 Real  0.1 Hype  0.13 Naive  0.13
The real value of Emmaus OTC Stock, also known as its intrinsic value, is the underlying worth of Emmaus Life Sciences OTC Stock, which is reflected in its stock price. It is based on Emmaus Life's financial performance, assets, liabilities, growth prospects, management team, or industry conditions. The intrinsic value of Emmaus Life's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Emmaus Life's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
0.10
Real Value
35.11
Upside
Estimating the potential upside or downside of Emmaus Life Sciences helps investors to forecast how Emmaus otc stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Emmaus Life more accurately as focusing exclusively on Emmaus Life's fundamentals will not take into account other important factors:
Bollinger
Band Projection (param)
LowerMiddle BandUpper
0.080.110.14
Details
Hype
Prediction
LowEstimatedHigh
0.010.1335.14
Details
Naive
Forecast
LowNext ValueHigh
00.1335.14
Details

Emmaus Life Valuation Ratios as Compared to Competition

Comparative valuation techniques use various fundamental indicators to help in determining Emmaus Life's current stock value. Our valuation model uses many indicators to compare Emmaus Life value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Emmaus Life competition to find correlations between indicators driving Emmaus Life's intrinsic value. More Info.
Emmaus Life Sciences is one of the top stocks in net asset category among related companies. It is one of the top stocks in price to sales category among related companies . The ratio of Net Asset to Price To Sales for Emmaus Life Sciences is about  53,699,953 . Comparative valuation analysis is a catch-all model that can be used if you cannot value Emmaus Life by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Emmaus Life's OTC Stock . Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Emmaus Life's earnings, one of the primary drivers of an investment's value.
Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Emmaus Life's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Emmaus Life and how it compares across the competition.

About Emmaus Life Valuation

The otc valuation mechanism determines the current worth of Emmaus Life Sciences on a weekly basis. We use both absolute as well as relative valuation methodologies to arrive at the intrinsic value of Emmaus Life Sciences. In general, an absolute valuation paradigm, as applied to this otc stock, attempts to find the value of Emmaus Life Sciences based exclusively on its fundamental and basic technical indicators. By analyzing Emmaus Life's financials, quarterly and monthly indicators, and its related drivers such as dividends, operating cash flow, and various types of growth rates, we attempt to find the most accurate representation of Emmaus Life's intrinsic value. In some cases, mostly for established, large-cap companies, we also incorporate more traditional valuation methods such as dividend discount, discounted cash flow, or asset-based models. As compared to an absolute model, our relative valuation model uses a comparative analysis of Emmaus Life. We calculate exposure to Emmaus Life's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Emmaus Life's related companies.
Emmaus Life Sciences, Inc., a commercial-stage biopharmaceutical company, discovers, develops, markets, and sells treatments and therapies primarily for rare and orphan diseases in the United States and internationally. Emmaus Life Sciences, Inc. was founded in 2000 and is headquartered in Torrance, California. Emmaus Life operates under Biotechnology classification in the United States and is traded on OTC Exchange. It employs 58 people.

8 Steps to conduct Emmaus Life's Valuation Analysis

OTC Stock's valuation is the process of determining the worth of any otc stock in monetary terms. It estimates Emmaus Life's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of otc stock valuation is a single number representing a OTC Stock's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Emmaus Life's valuation analysis, follow these 8 steps:
  • Gather financial information: Obtain Emmaus Life's financial statements, including balance sheets, income statements, and cash flow statements.
  • Determine Emmaus Life's revenue streams: Identify Emmaus Life's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
  • Analyze market data: Research Emmaus Life's industry and market trends, including the size of the market, growth rate, and competition.
  • Establish Emmaus Life's growth potential: Evaluate Emmaus Life's management, business model, and growth potential.
  • Determine Emmaus Life's financial performance: Analyze its financial statements to assess its historical performance and future potential.
  • Choose a valuation method: Consider the OTC Stock's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
  • Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Emmaus Life's estimated value.
  • Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Note: This is a general outline, and different approaches and methods may be used depending on the type and size of the otc stock being valued. We also recomment to seek professional assistance to ensure accuracy.

Emmaus Life Growth Indicators

Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines. Note, investing in growth stocks can be very risky. If the company such as Emmaus Life does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
Common Stock Shares Outstanding49.3 M
Retained Earnings-241.3 M
Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any otc stock could be tightly coupled with the direction of predictive economic indicators such as signals in population.
You can also try the Money Flow Index module to determine momentum by analyzing Money Flow Index and other technical indicators.

Other Consideration for investing in Emmaus OTC Stock

If you are still planning to invest in Emmaus Life Sciences check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Emmaus Life's history and understand the potential risks before investing.
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
FinTech Suite
Use AI to screen and filter profitable investment opportunities
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Equity Valuation
Check real value of public entities based on technical and fundamental data